Cargando…

Targeted Therapy in Ovarian Cancer

Ovarian cancer is the most common cause of mortality of tumors from gynecologic origin and is often diagnosed after patients have already progressed to advanced disease stage. The current standard of care for treatment of ovarian cancer includes cytoreductive surgery followed by adjuvant chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willmott, Lyndsay J., Fruehauf, John P.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814233/ https://www.ncbi.nlm.nih.gov/pubmed/20130818 http://dx.doi.org/10.1155/2010/740472

Ejemplares similares

Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture
por: Trapp, Valerie, et al.
Publicado: (2010)

Targeted Therapies in Epithelial Ovarian Cancer
por: Barrena Medel, Nicanor I., et al.
Publicado: (2010)

Targeted Therapies in Epithelial Ovarian Cancer
por: Dean, Emma, et al.
Publicado: (2010)

Ovarian Cancer: Biomarkers and Targeted Therapy
por: Radu, Mihaela Raluca, et al.
Publicado: (2021)

Ovarian Cancer: Opportunity for Targeted Therapy
por: Tagawa, Tomoko, et al.
Publicado: (2012)

New perspectives on targeted therapy in ovarian cancer
por: Coward, Jermaine IG, et al.
Publicado: (2015)

Ovarian cancer stem cells and targeted therapy
por: Keyvani, Vahideh, et al.
Publicado: (2019)

Targeting the EGF Receptor for Ovarian Cancer Therapy
por: Zeineldin, Reema, et al.
Publicado: (2010)

Ovarian cancer: emerging molecular-targeted therapies
por: Sourbier, Carole
Publicado: (2012)

PTTG: an important target gene for ovarian cancer therapy
por: Panguluri, Siva Kumar, et al.
Publicado: (2008)

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
por: Langdon, Simon P., et al.
Publicado: (2020)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
por: Gupta, Vijayalaxmi, et al.
Publicado: (2018)

Ferroptosis: A New Promising Target for Ovarian Cancer Therapy
por: Zhao, Hongjiang, et al.
Publicado: (2022)

Calcium signals and potential therapy targets in ovarian cancer (Review)
por: Deng, Fengying, et al.
Publicado: (2023)

Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy
por: Yan, Tianqing, et al.
Publicado: (2023)

Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
por: Zhan, Qinglei, et al.
Publicado: (2013)

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies
por: Mantia-Smaldone, Gina M, et al.
Publicado: (2010)

Potential Targeted Therapies in Ovarian Cancer
por: Sisman, Yagmur, et al.
Publicado: (2022)

Targeted therapy of ovarian cancer including immune check point inhibitor
por: Kim, Jin Young, et al.
Publicado: (2017)

The target therapy of ovarian clear cell carcinoma
por: Jin, Ying, et al.
Publicado: (2014)

Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways
por: Hiss, Donavon
Publicado: (2012)

Advances in ovarian cancer therapy
por: Cortez, Alexander J., et al.
Publicado: (2017)

Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments
por: Lokadasan, Rajitha, et al.
Publicado: (2016)

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy
por: Harbin, Laura M., et al.
Publicado: (2022)

Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer
por: Wallace-Povirk, Adrianne, et al.
Publicado: (2021)

Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies
por: Rosario, Roseanne, et al.
Publicado: (2022)

A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer
por: Zhuang, Eric, et al.
Publicado: (2021)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning
por: Topaly, J, et al.
Publicado: (2002)

Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy
por: Yamashita, Yoriko
Publicado: (2015)

Claudins Overexpression in Ovarian Cancer: Potential Targets for Clostridium Perfringens Enterotoxin (CPE) Based Diagnosis and Therapy
por: English, Diana P., et al.
Publicado: (2013)

Targeting purine metabolism in ovarian cancer
por: Liu, Jingchun, et al.
Publicado: (2022)

Epithelial Ovarian Cancer: Focus on Targeted Therapy
por: Markman, M., et al.
Publicado: (2010)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy
por: Bai, Huimin, et al.
Publicado: (2016)

Mucins in ovarian cancer diagnosis and therapy
por: Chauhan, Subhash C, et al.
Publicado: (2009)

Antiangiogenic therapies in ovarian cancer
por: Reinthaller, Alexander
Publicado: (2016)

EpCAM-Binding DARPins for Targeted Photodynamic Therapy of Ovarian Cancer
por: van den Brand, Dirk, et al.
Publicado: (2020)

Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs
por: Rath, Kellie S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ufp4tj2ue9r4ftq84bfs263f5a